| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,637 | 8,780 | 8,874 | 11,320 | | Cost of Revenue | 2,405 | 2,578 | 2,298 | 2,328 | | | Gross Profit | 6,232 | 6,202 | 6,576 | 8,992 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,145 | 1,174 | 1,328 | 1,219 | | Non Recurring | 155 | 116 | 132 | 1,876 | | Others | 7,287 | 6,845 | 7,088 | 6,950 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,354) | (1,933) | (1,971) | (1,054) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,023 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (8) | (1,933) | (1,971) | (1,054) | | Interest Expense | (61) | 68 |
-
|
-
| | Income Before Tax | 53 | (2,002) | (1,971) | (1,054) | | Income Tax Expense | (290) | (1,073) | (1,026) | (179) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 667 | (929) | (945) | (875) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 343 | (929) | (945) | (875) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $343 | ($929) | ($945) | ($875) |
|
0.51% Nasdaq 
0.15 (0.58%) 
Income Statement
